Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.
27.03.2025 10:56:04

EQS-PVR: CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: CompuGroup Medical SE & Co. KGaA
CompuGroup Medical SE & Co. KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

27.03.2025 / 10:56 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


Notification of Major Holdings

1. Details of issuer
Name: CompuGroup Medical SE & Co. KGaA
Street: Maria Trost 21
Postal code: 56070
City: Koblenz
Germany
Legal Entity Identifier (LEI): 529900CUXZGOCJZR7O57

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: The Goldman Sachs Group, Inc.
City of registered office, country: Wilmington, DE, United States of America (USA)

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
20 March 2025

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)
% of voting rights through instruments
(total of 7.b.1 + 7.b.2)
Total of both in %
(7.a. + 7.b.)
Total number of voting rights pursuant to Sec. 41 WpHG
New 2.68 % 2.20 % 4.88 % 53734576
Previous notification 3.43 % 1.32 % 4.75 % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
Direct
(Sec. 33 WpHG)
Indirect
(Sec. 34 WpHG)
DE000A40UTN2 0 1031 0 % 0.002 %
DE000A288904 0 1438310 0 % 2.68 %
Total 1439341 2.68 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
Right To Recall Open 296527 0.55 %
Right Of Use Open 503015 0.94 %
    Total 799542 1.49 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
Swap 05.02.2035 Cash 384698 0.72 %
      Total 384698 0.72 %

8. Information in relation to the person subject to the notification obligation
  Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)
The Goldman Sachs Group, Inc. % % %
GSAM Holdings LLC % % %
Goldman Sachs Asset Management, L.P. % % %
- % % %
The Goldman Sachs Group, Inc. % % %
Goldman Sachs Bank USA % % %
Goldman Sachs Bank Europe SE % % %
- % % %
The Goldman Sachs Group, Inc. % % %
Goldman Sachs & Co. LLC % % %
- % % %
The Goldman Sachs Group, Inc. % % %
Goldman Sachs (UK) L.L.C. % % %
Goldman Sachs Group UK Limited % % %
Goldman Sachs International % % %

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
26 March 2025



27.03.2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE & Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

 
End of News EQS News Service

2107532  27.03.2025 CET/CEST

Analysen zu CompuGroup Medical SE & Co. KGaA

  • Alle
  • Kaufen
  • Hold
  • Verkaufen
  • ?
18.03.25 CompuGroup Medical Buy Baader Bank
06.03.25 CompuGroup Medical Buy Baader Bank
24.02.25 CompuGroup Medical Buy Baader Bank
03.02.25 CompuGroup Medical Buy Baader Bank
13.01.25 CompuGroup Medical Hold Jefferies & Company Inc.
Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen

Investieren in Rüstungsaktien – Wall Street Live mit Tim Schäfer

Tim Schäfer analysiert im Gespräch mit David Kunz (COO der BX Swiss) die spannendsten Defense-Aktien aus Europa und den USA. Sind Rheinmetall, Palantir oder Lockheed Martin noch kaufenswert – oder schon überbewertet?
Wir sprechen über die Rolle von Trumps NATO-Druck, die massive Aufrüstung in Europa und warum gerade europäische Rüstungsaktien boomen.

✅ Top-Performer 2024
✅ Value- und Dividenden-Checks
✅ Geheimtipps wie BAE Systems, Thales & Co.
✅ Palantir als digitaler Profiteur

In unserem zweiwöchigen Format „Wall Street Live“ mit Tim Schäfer behandeln wir Topaktuelle Themen des Marktgeschehens.
🛑 Wichtig: Das Thema Rüstung ist gesellschaftlich wie ethisch komplex – in diesem Video beleuchten wir vor allem die börsentechnische Entwicklung und die wirtschaftlichen Auswirkungen globaler Ereignisse.

👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/

Investieren in Rüstungsaktien – Wall Street Live mit Tim Schäfer

Mini-Futures auf SMI

Typ Stop-Loss Hebel Symbol
Short 13’045.36 13.76 U80SSU
Short 13’541.30 8.99 BK6SXU
SMI-Kurs: 12’279.48 03.04.2025 17:31:25
Long 11’820.00 19.95
Long 11’540.00 13.96
Long 10’970.55 8.73 SSQMQU
Die Produktdokumentation, d.h. der Prospekt und das Basisinformationsblatt (BIB), sowie Informationen zu Chancen und Risiken, finden Sie unter: https://keyinvest-ch.ubs.com

Roche am 26.03.2025

Chart

finanzen.net News

Datum Titel
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
{{ARTIKEL.NEWS.BODY.TITEL}}